Cargando…

Prospective Multicenter Open-Label One-Arm Trial Investigating a Pumpkin Seed, Isoflavonoids, and Cranberry Mix in Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: A Pilot Study

Phytotherapy for lower urinary tract symptoms (LUTSs) due to benign prostate hyperplasia (BPH) is progressively demanded by patients and trusted by physicians. The aim was to assess the efficacy of a mix of pumpkin seed extract, soy germ isoflavonoids, and cranberry (Novex®) in the management of mil...

Descripción completa

Detalles Bibliográficos
Autores principales: Nemr, Elie, El Helou, Elie, Mjaess, Georges, Semaan, Albert, Chebel, Josselin Abi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083134/
https://www.ncbi.nlm.nih.gov/pubmed/32215007
http://dx.doi.org/10.1155/2020/6325490
_version_ 1783508478027890688
author Nemr, Elie
El Helou, Elie
Mjaess, Georges
Semaan, Albert
Chebel, Josselin Abi
author_facet Nemr, Elie
El Helou, Elie
Mjaess, Georges
Semaan, Albert
Chebel, Josselin Abi
author_sort Nemr, Elie
collection PubMed
description Phytotherapy for lower urinary tract symptoms (LUTSs) due to benign prostate hyperplasia (BPH) is progressively demanded by patients and trusted by physicians. The aim was to assess the efficacy of a mix of pumpkin seed extract, soy germ isoflavonoids, and cranberry (Novex®) in the management of mild to moderate LUTS in BPH patients. Male patients aged ≥40 years, who had had mild to moderate LUTS for >6 months at screening, with no previous therapy or who are still symptomatic despite current use of alpha-blockers, were recruited. Exclusion criteria were an IPSS >19 and an age >80 years. The mixed compound was administered orally, daily, for 3 months. Patients were evaluated by means of IPSS, urological quality of life (uQoL) index, and International Index of Erectile Function (IIEF-5) at 3 visits: baseline (visit 1), 30 days (visit 2), and 90 days after treatment (visit 3). Among 163 screened patients, 128 patients (61.8 ± 9.9 years) were recruited. IPSS improved from 15 (Q1 : 12–Q3 : 17) in visit 1, to 11 (Q1 : 8–Q3 : 14) in visit 2, and to 9 (Q1 : 6–Q3 : 12) in visit 3 (p < 0.001). uQoL improved from 4 (3–4) in visit 1, to 3 (2–3) in visit 2, and to 2 (1–2) in visit 3 (p < 0.001). The patients had an IIEF-5 score of 15 (12–18.7) in visit 1, 15 (12–18) in visit 2, and 17 (13–19) in visit 3 (p=0.99 visits 1 vs. 2, p=0.004 visits 2 vs. 3, and p=0.001 visits 1 vs. 3). Treating mild to moderate LUTS/BPH patients with Novex® might therefore relieve symptoms, improve the quality of life, and have a mild beneficial effect on erectile function.
format Online
Article
Text
id pubmed-7083134
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-70831342020-03-25 Prospective Multicenter Open-Label One-Arm Trial Investigating a Pumpkin Seed, Isoflavonoids, and Cranberry Mix in Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: A Pilot Study Nemr, Elie El Helou, Elie Mjaess, Georges Semaan, Albert Chebel, Josselin Abi Adv Urol Research Article Phytotherapy for lower urinary tract symptoms (LUTSs) due to benign prostate hyperplasia (BPH) is progressively demanded by patients and trusted by physicians. The aim was to assess the efficacy of a mix of pumpkin seed extract, soy germ isoflavonoids, and cranberry (Novex®) in the management of mild to moderate LUTS in BPH patients. Male patients aged ≥40 years, who had had mild to moderate LUTS for >6 months at screening, with no previous therapy or who are still symptomatic despite current use of alpha-blockers, were recruited. Exclusion criteria were an IPSS >19 and an age >80 years. The mixed compound was administered orally, daily, for 3 months. Patients were evaluated by means of IPSS, urological quality of life (uQoL) index, and International Index of Erectile Function (IIEF-5) at 3 visits: baseline (visit 1), 30 days (visit 2), and 90 days after treatment (visit 3). Among 163 screened patients, 128 patients (61.8 ± 9.9 years) were recruited. IPSS improved from 15 (Q1 : 12–Q3 : 17) in visit 1, to 11 (Q1 : 8–Q3 : 14) in visit 2, and to 9 (Q1 : 6–Q3 : 12) in visit 3 (p < 0.001). uQoL improved from 4 (3–4) in visit 1, to 3 (2–3) in visit 2, and to 2 (1–2) in visit 3 (p < 0.001). The patients had an IIEF-5 score of 15 (12–18.7) in visit 1, 15 (12–18) in visit 2, and 17 (13–19) in visit 3 (p=0.99 visits 1 vs. 2, p=0.004 visits 2 vs. 3, and p=0.001 visits 1 vs. 3). Treating mild to moderate LUTS/BPH patients with Novex® might therefore relieve symptoms, improve the quality of life, and have a mild beneficial effect on erectile function. Hindawi 2020-01-13 /pmc/articles/PMC7083134/ /pubmed/32215007 http://dx.doi.org/10.1155/2020/6325490 Text en Copyright © 2020 Elie Nemr et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Nemr, Elie
El Helou, Elie
Mjaess, Georges
Semaan, Albert
Chebel, Josselin Abi
Prospective Multicenter Open-Label One-Arm Trial Investigating a Pumpkin Seed, Isoflavonoids, and Cranberry Mix in Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: A Pilot Study
title Prospective Multicenter Open-Label One-Arm Trial Investigating a Pumpkin Seed, Isoflavonoids, and Cranberry Mix in Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: A Pilot Study
title_full Prospective Multicenter Open-Label One-Arm Trial Investigating a Pumpkin Seed, Isoflavonoids, and Cranberry Mix in Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: A Pilot Study
title_fullStr Prospective Multicenter Open-Label One-Arm Trial Investigating a Pumpkin Seed, Isoflavonoids, and Cranberry Mix in Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: A Pilot Study
title_full_unstemmed Prospective Multicenter Open-Label One-Arm Trial Investigating a Pumpkin Seed, Isoflavonoids, and Cranberry Mix in Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: A Pilot Study
title_short Prospective Multicenter Open-Label One-Arm Trial Investigating a Pumpkin Seed, Isoflavonoids, and Cranberry Mix in Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: A Pilot Study
title_sort prospective multicenter open-label one-arm trial investigating a pumpkin seed, isoflavonoids, and cranberry mix in lower urinary tract symptoms/benign prostatic hyperplasia: a pilot study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083134/
https://www.ncbi.nlm.nih.gov/pubmed/32215007
http://dx.doi.org/10.1155/2020/6325490
work_keys_str_mv AT nemrelie prospectivemulticenteropenlabelonearmtrialinvestigatingapumpkinseedisoflavonoidsandcranberrymixinlowerurinarytractsymptomsbenignprostatichyperplasiaapilotstudy
AT elhelouelie prospectivemulticenteropenlabelonearmtrialinvestigatingapumpkinseedisoflavonoidsandcranberrymixinlowerurinarytractsymptomsbenignprostatichyperplasiaapilotstudy
AT mjaessgeorges prospectivemulticenteropenlabelonearmtrialinvestigatingapumpkinseedisoflavonoidsandcranberrymixinlowerurinarytractsymptomsbenignprostatichyperplasiaapilotstudy
AT semaanalbert prospectivemulticenteropenlabelonearmtrialinvestigatingapumpkinseedisoflavonoidsandcranberrymixinlowerurinarytractsymptomsbenignprostatichyperplasiaapilotstudy
AT chebeljosselinabi prospectivemulticenteropenlabelonearmtrialinvestigatingapumpkinseedisoflavonoidsandcranberrymixinlowerurinarytractsymptomsbenignprostatichyperplasiaapilotstudy